Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
VILNIUS UNIVERSITY is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These cases are assigned to 4 distinct examiners, indicating that each active matter is being reviewed by a different individual. This distribution requires the university to manage four separate examiner relationships simultaneously. These actions are spread across 2 distinct art units, suggesting that the university's biotechnology research is categorized into two different technical subgroups at the USPTO.
FLINDERS, JEREMY C is identified as the busiest examiner for the university, though this individual is only responsible for 1 pending office action. This means the active workload is evenly distributed among the examiners. For the practitioner, this requires managing four different examiner styles while working within the frameworks of 2 distinct art units. The 4 pending office actions represent a moderate level of activity in the Biotechnology & Pharmaceuticals field. With multiple examiners involved, the university must maintain a consistent technical narrative while adapting to the individual procedural preferences of each examiner across its active cases.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §102 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLINDERS, JEREMY C | 1 | 63.5% | +16.7% |
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
| BURKETT, DANIEL JOHN | 1 | 62.6% | +33.2% |
| CHUNDURU, SURYAPRABHA | 1 | 53.3% | +17.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916056 | METHODS AND COMPOSITIONS FOR NONINVASIVE PRENATAL DIAGNOSIS THROUGH TARGETED COVALENT LABELING OF GENOMIC SITES | CHUNDURU, SURYAPRABHA | 70d overdue |
| 18349394 | COMPOSITION AND THE USE OF CELL LYSIS REAGENTS | GREENE, CAROLYN LEE | 14d |
| 18715381 | BARCODING NUCLEIC ACID MOLECULES DERIVED FROM INDIVIDUAL CELLS | FLINDERS, JEREMY C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916056 | METHODS AND COMPOSITIONS FOR NONINVASIVE PRENATAL DIAGNOSIS THROUGH TARGETED COVALENT LABELING OF GENOMIC SITES | CHUNDURU, SURYAPRABHA | 70d overdue |
| 18039644 | CARBONIC ANHYDRASE INHIBITORS SYNTHESIZED ON INTERCONNECTING LINKER CHAINS | BURKETT, DANIEL JOHN | 50d overdue |
| 18349394 | COMPOSITION AND THE USE OF CELL LYSIS REAGENTS | GREENE, CAROLYN LEE | 14d |
| 18715381 | BARCODING NUCLEIC ACID MOLECULES DERIVED FROM INDIVIDUAL CELLS | FLINDERS, JEREMY C | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18715381 | BARCODING NUCLEIC ACID MOLECULES DERIVED FROM INDIVIDUAL CELLS | FLINDERS, JEREMY C | — | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18349394 | COMPOSITION AND THE USE OF CELL LYSIS REAGENTS | GREENE, CAROLYN LEE | 1681 | §101§102§103§112 | Final Rejection | 14d | Pending | Jul 10, 2023 |
| 18039644 | CARBONIC ANHYDRASE INHIBITORS SYNTHESIZED ON INTERCONNECTING LINKER CHAINS | BURKETT, DANIEL JOHN | 1624 | §102 | Final Rejection | 50d overdue | Pending | May 31, 2023 |
| 17916056 | METHODS AND COMPOSITIONS FOR NONINVASIVE PRENATAL DIAGNOSIS THROUGH TARGETED COVALENT LABELING OF GENOMIC SITES | CHUNDURU, SURYAPRABHA | 1681 | §101§103§112 | Final Rejection | 70d overdue | Pending | Sep 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial